Skip to main content
. 2021 Jan 14;6(3):2074–2084. doi: 10.1021/acsomega.0c05054

Table 3. Impact of Rosuvastatin on Hematological and Biochemical Parameters.

parameters normal control disease control (3 mL/kg distilled water) piroxicam (10 mg/kg) rosuvastatin (40 mg/kg)
CRP (mg/L) 3.5 ± 0.86*** 38.83 ± 1.53 10.35 ± 1.51*** 11.15 ± 0.39***
Hb (g/dL) 14.18 ± 0.65*** 8.81 ± 0.97 13.41 ± 0.68** 12.15 ± 0.83***
WBCs (×103/μL) 8.1 ± 0.63*** 14.01 ± 1.01 9.23 ± 0.54** 9.49 ± 0.46***
RBCs (×103/μL) 8.78 ± 0.66*** 5.83 ± 0.42 7.88 ± 0.80** 7.73 ± 0.62***
platelets (×103/μL) 840 ± 20.5*** 1351 ± 18.65 891 ± 32.12*** 901 ± 19.43***
ESR (MM/1st h) 3.55 ± 0.45*** 8.65 ± 0.41 4.11 ± 0.55*** 4.38 ± 0.60***
RF (IU/mL) 6.35 ± 0.59*** 35.38 ± 0.29 9.53 ± 0.91*** 9.86 ± 0.78***
AST (U/L) 112.43 ± 5.10*** 149 ± 3.97 119.02 ± 4.52** 120.01 ± 5.04**
ALT (U/L) 19.87 ± 5.38*** 50.21 ± 4.21 21.43 ± 2.73** 22.30 ± 2.06***
ALP (U/L) 157.23 ± 3.85*** 273.11 ± 4.54 165.56 ± 3.14*** 167.31 ± 5.37***
urea (mg/dL) 13.53 ± 1.65*** 31.83 ± 1.97 16.74 ± 1.63** 17.80 ± 2.04***
creatinine (mg/dL) 0.38 ± 0.11*** 0.97 ± 0.05 0.51 ± 0.03*** 0.56 ± 0.07**
a

Data are represented as mean ± SEM, where n = 6, and analyzed by two-way ANOVA followed by the Bonferroni post-test, where ***p < 0.001, **p < 0.01, *p < 0.05, ns = not significant.